Immunotherapy for Blood Disorders

Immunotherapy harnesses the body’s immune system to target abnormal blood cells in certain hematologic conditions, including leukemia and lymphoma. This advanced treatment may involve monoclonal antibodies or immune-modulating agents designed to specifically attack diseased cells while preserving healthy tissue. Immunotherapy offers a targeted approach that can improve outcomes and reduce some side effects compared to traditional therapies.